305 related articles for article (PubMed ID: 24727978)
21. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
[TBL] [Abstract][Full Text] [Related]
22. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation.
Horiuchi H; Parajuli B; Komiya H; Ogawa Y; Jin S; Takahashi K; Azuma YT; Tanaka F; Suzumura A; Takeuchi H
Front Immunol; 2021; 12():615898. PubMed ID: 33776998
[TBL] [Abstract][Full Text] [Related]
24. Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.
Holz K; Prinz M; Brendecke SM; Hölscher A; Deng F; Mitrücker HW; Rose-John S; Hölscher C
Front Immunol; 2018; 9():836. PubMed ID: 29770132
[TBL] [Abstract][Full Text] [Related]
25. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
26. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
27. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
28. Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson's Disease.
Burgaz S; García C; Gómez-Cañas M; Muñoz E; Fernández-Ruiz J
Molecules; 2019 Jul; 24(15):. PubMed ID: 31349553
[TBL] [Abstract][Full Text] [Related]
29. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
[TBL] [Abstract][Full Text] [Related]
30. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380
[TBL] [Abstract][Full Text] [Related]
31. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
32. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
[TBL] [Abstract][Full Text] [Related]
33. AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis.
Mangalam AK; Rattan R; Suhail H; Singh J; Hoda MN; Deshpande M; Fulzele S; Denic A; Shridhar V; Kumar A; Viollet B; Rodriguez M; Giri S
J Immunol; 2016 Aug; 197(3):747-60. PubMed ID: 27354217
[TBL] [Abstract][Full Text] [Related]
34. Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.
Kuo PC; Weng WT; Scofield BA; Paraiso HC; Brown DA; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2020 Apr; 17(1):138. PubMed ID: 32349768
[TBL] [Abstract][Full Text] [Related]
35. Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Wegner C; Stadelmann C; Pförtner R; Raymond E; Feigelson S; Alon R; Timan B; Hayardeny L; Brück W
J Neuroimmunol; 2010 Oct; 227(1-2):133-43. PubMed ID: 20684995
[TBL] [Abstract][Full Text] [Related]
36. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
Natarajan C; Bright JJ
J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272
[TBL] [Abstract][Full Text] [Related]
37. Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Wang J; Chen F; Zheng P; Deng W; Yuan J; Peng B; Wang R; Liu W; Zhao H; Wang Y; Wu G
Exp Neurol; 2012 Jul; 236(1):79-87. PubMed ID: 22524989
[TBL] [Abstract][Full Text] [Related]
38. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
Bhasin M; Wu M; Tsirka SE
BMC Immunol; 2007 Jul; 8():10. PubMed ID: 17634104
[TBL] [Abstract][Full Text] [Related]
39. Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response.
Wu Z; Nagano I; Asano K; Takahashi Y
Parasitol Res; 2010 Oct; 107(5):1173-88. PubMed ID: 20661746
[TBL] [Abstract][Full Text] [Related]
40. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps.
Dasgupta S; Zhou Y; Jana M; Banik NL; Pahan K
J Immunol; 2003 Apr; 170(7):3874-82. PubMed ID: 12646656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
